Merz promotes Church to VP, CCO
This article was originally published in Scrip
Merz, a company focused on medications for treating neurological and psychiatric illnesses, has promoted Katrina Church to vice-president and chief compliance officer. Ms Church joined Merz in November 2009 and has over 20 years' legal experience. Prior to joining Merz she served as general counsel at Connetics before its acquisition by Stiefel Laboratories.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.